For the industry to develop healthily in the long run, it needs to be able to grow continuously. Currently, chronic disease treatment and pharmaceuticals have the most promising role to play in this engine! The rapid aging of the population is the main fuel for the development of the chronic disease pharmaceutical industry. According to the United Nations' estimation, by 2050, 1/6 of the world's population will be over the age of 65, and this aging society will give rise to a huge potential for the chronic disease treatment market. Thanks to technological advances in molecular biology and cellular therapy, diseases that were difficult to treat in the past can be repaired by using regenerative medicine techniques to repair damaged tissues. For example, eye diseases and arthritis, which are independent diseases that have the most direct impact on contact with the outside world in old age, have been the hot items of research and development in recent years.